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Objective. Exercise advice is the main treatment for symptom relief in the UK for patients with mild to moderate
Intermittent Claudication (IC). Would a weekly exercise and motivation class for 6 months offer adjuvant benefit over
written and verbal exercise advice alone?
Patients and methods. Fifty-nine patients attending a regional vascular centre for whom IC was the main factor affecting
mobility were randomised to either exercise advice alone (n ¼ 30) or exercise advice with a once a week 45 min supervised
exercise/motivation class (n ¼ 29). The mean age was 68 years. Baseline and 6-month assessment included a Quality of Life
Questionnaire—the Short-Form-36, the Charing Cross Symptom Specific Claudication Questionnaire (CCCQ) and
treadmill walking distance (3.5 km/h 12%).
Results. At 6-month follow-up the supervised exercise group had improved their treadmill walking by 129% compared to
69% in the advice alone group (p ¼ 0.001). This significant improvement was maintained at the subsequent 9 and 12-month
follow-up assessments. By the 9-month stage the advice only group CCCQ score had improved 16% from baseline, while the
supervised exercise group had a significantly better 43% improvement in base line score (p , 0.05). Self reported frequency
of walks was higher in the exercise class group being significant for improvement in CCCQ score.
Conclusion. A weekly, supervised exercise and motivation class for a 6-month period provides a significant improvement in
patients’ symptoms, quality of life, and distance walked compared with advice alone and this improvement continues after
attendance at class has ceased.
Key Words: Peripheral arterial disease; Intermittent claudication; Exercise; Treadmill; Six-minute walk; Quality of life;
Ankle brachial pressure index.
Introduction
Claudication represents the most common new pro-
blem referred to vascular surgeons.1 This is not
surprising as symptoms of intermittent claudication
affect 3–7% of the general population with up to 20%
of the population over the age of 75 years having
peripheral arterial disease.2,3 Traditionally sufferers of
intermittent claudication are referred to vascular out-
patients as some form of invasive intervention was
previously a more common form of treatment.
However, in more recent times, for patients with
mild to moderate symptoms, conservative treatment
in the form of risk factor modification and exercise
rehabilitation has become the cornerstone of manage-
ment.4 The conservative approach benefits patients
not only in improving their symptoms, but also in
reducing the high mortality from cardiovascular
events that afflicts this group of patients.5
Whilst risk factor modification treatments in the
form of lipid lowering therapy, antihypertension
treatment, diabetic control and antiplatelet therapy
are generally agreed to be beneficial, there is disagree-
ment over the best form of exercise therapy. Factors
such as the type of exercise, frequency of exercise, level
of supervision and degree of improvement are all in
dispute. One of the problems is the lack of trials
addressing these specific points. The Cochrane review
of the subject of exercise therapy for intermittent
claudication identified only 10 suitable trials with an
average of 25 patients.6 From this review it was
concluded that a thrice-weekly regime of walking
to near maximum pain provided the best improve-
ment in claudication symptoms. Programmes lasting
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6-months seemed to give greater improvements than
shorter programmes. Supervised exercise appeared to
give better results than unsupervised programmes.
However, one important unanswered question was
the level of supervision required for an exercise
programme to be effective.
It is currently known that few centres hold thrice-
weekly supervised exercise classes for patients with
claudication.7 The sheer number of sufferers creates
important financial and logistical problems with
regards to implementing exercise programmes. For
this reason most centres currently rely on exercise
advice alone for the treatment of claudicants with mild
to moderate symptoms. The question to be answered,
therefore, is would a more manageable supervised
programme, for instance with a reduced frequency
rate of once a week give a significant improvement on
the current widespread practice of simply giving
exercise advice alone?
Method
Patient recruitment
Patients attending a regional vascular centre for whom
intermittent claudication was the main factor affecting
mobility were considered (Fig. 1). Ethical approval
was gained and all patients consented involvement in
the trial.
Inclusion criteria:
All patients had:
A resting Ankle:Brachial Pressure Index (ABPI) ,0.9
or a positive response to a validated stress test (a
drop in ankle pressure of .30 mmHg following
1 min of treadmill walking at 10% slope and
4 km/h measured 40 s post exercise).8
Peripheral arterial disease, confirmed by duplex scans
of the affected leg(s).
A positive response to the Edinburgh Claudication
Questionnaire, a self-administered tool with sensi-
tivity of 91% and specificity of 99% for the
diagnosis of IC.8
A minimum of a 6-month period of stable symptoms
of mild to moderate IC (able to walk.300 m on the
flat in 6 min).
Exclusion criteria:
Not fulfilling all inclusion criteria.
Severe IC deemed to warrant radiological or surgical
intervention.
Critical ischaemia.
Significant co-morbidity preventing participation in
an exercise programme.
Vascular or endovascular intervention within the last 2
years.
Having received pharmacological agents aimed at
improving symptoms within the previous 6-months.
All patients were given best medical treatment,
namely appropriate initiation of anti-platelet therapy,
anti-hypertensive therapy, cholesterol-lowering agents
and diabetic control. At the end of the consultation
each patient received both verbal and written exercise
advice. The exercise advice recommended a program
of walking at least three times a week to near maximal
pain, for at least half an hour per session. Additional
leg exercises to be performed at home, such as stair
climbing and tiptoe walking, were also advised. After
this, patients were computer randomised either to be
reviewed on a 3-monthly basis only (exercise advice
alone group) or, in addition, asked to attend a once
weekly 45 min supervised exercise and motivation
class for a 6-month period (supervised exercise group).
Exercise class
The 45 min class was conducted under physiotherapy
and medical supervision in a standard hospital gym. It
commenced with a 5–10 min talk on the benefits of
walking. This was followed by approximately half an
hour of exercise. This consisted of a walking circuit
and performing at seven 2 min exercise stations aimed
at lower limb strengthening. These were: stair-climb-
ing, low-step climbing, high-step climbing, tip toe
walking, standing on tip toe from flat, standing on tip
toe from ankle dorsi-flexion and power-jogger walk-
ing. Each exercise was performed for a 2 min period
interspersed by circuit walking for 2 min. The patient
determined the rate at which each exercise was
performed. At any one time seven patients were at
exercise stations and seven patients were on the
walking circuit swapping after 2 min, allowing 14
patients to attend each class.
Outcome measures
All assessments were conducted immediately pre-trial
(baseline) and subsequently at 3 monthly periods.
Outcome measures included those recommended by
the Trans-Atlantic Inter-Society Consensus (TASC) on
Management of Peripheral Arterial Disease9 and
consisted of:
. A Generic Health Related Quality of Life Ques-
tionnaire (HRQL) the Short Form-36 (SF-36).
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. A symptom specific HRQL measure, the validated
Charing Cross Claudication Questionnaire (CCCQ),
lower scores indicating better quality of life (QOL).10
. Initial Claudication Distance (ICD), the distance
walked until the onset of claudication pain and
Absolute Claudication Distance (ACD) the maxi-
mum distance walked until the subject is forced to
stop due to pain measured on a fixed load treadmill
at 3.5 km/h with a 12% gradient. At baseline the
subjects were assessed on two consecutive weeks,
to allow for familiarisation on the treadmill. All
patients stopped due to claudication pain. For each
patient the furthest distance walked at the two tests
was used as the base line value.
In addition the following were also measured:
. Resting Ankle:Brachial Pressure Index (ABPI). This
was calculated for both the anterior and posterior
tibial arteries. As both legs were obviously used in
the walking exercise the mean ABPI for the
individual was calculated and used for analysis.
. Self-reported compliance to the exercise advice
was obtained at 6 months: patients were asked
whether they walked ‘less than three times’,
‘three times’ or ‘more than three times’ a week.
The study hypothesis was that in patients attending
a weekly exercise and motivation class a significantly
improved CCCQ score would be achieved over those
receiving exercise advice alone. Sixty-six patients were
required to detect a 15% inter group difference in
CCCQ score with 90% power. Data analysis was
performed with the statistical package STATA. Linear
regression analysis adjusted for age was used to assess
Fig. 1. Trial design.
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ABPI, ICD and ACD. The Mann–Whitey U test was
used for differences in CCCQ score from baseline.
Results
Patient recruitment
A 6-month review of all patients attending a regional
centre’s vascular out-patients’ department identified
217 patients with symptomatic peripheral vascular
disease. After assessment, 59 were suitable for and
agreed to inclusion in the trial (Fig. 2). The mean age
was 67 years (range 45–86 years), 73% being male.
100% of subjects were either current or ex-smokers and
19% of patients were diabetic ðn ¼ 11Þ.
Computer randomisation to exercise advice alone
was n ¼ 30 and randomisation to exercise advice and
class was n ¼ 29. Analysis of patient’s characteristics
at baseline showed no statistically significant differ-
ence in sex distribution, smoking habit and diabetic
status. The statistically significant difference in age
was adjusted for in the analysis of the results. The
mean age of the exercise advice group was 70 years
and that for the supervised exercise group was 65
years.
At 6-month follow-up 56 of the 59 patients were
assessed. Three were unavailable: one had died from
recurrent pancreatitis, one had left the area and was
untraceable and one was abroad for a period of time.
At 12 month follow-up 55 patients were assessed: two
had died, the one from pancreatitis and a second
patient from pneumonia (one from each group), two
patients had moved from the area and were untrace-
able (one from each group). No deaths were attributed
to a vascular event during the year period.
Both the SF-36 and CCCQ were completed by the
patients, and were checked to ensure all questions had
been answered. Personnel blinded to the group
allocation compiled data. All ABPI measurements
were made by vascular technologists blinded to the
group allocation.
Generic Health Related Quality of Life Questionnaire
(HRQL) Short Form-36 (SF-36)
All patients were able to complete the SF-36. The SF-36
comprises eight domains. There was no significant
difference between baseline score in any of the
domains between the two groups at baseline. In
seven of the eight domains there was no significant
difference between the groups over the 12-month
period. In one domain, that of ‘Physical Functioning’
there was a borderline significant improvement in the
class group compared to the advice only group Fig. 3.
Charing Cross Claudication Questionnaire
All patients were able to complete the Charing Cross
Claudication Questionnaire (CCCQ), in which a lower
score indicates improved symptoms (Fig. 4). There
was no significant inter-group difference in baseline
score. There was drift towards significantly better
improvement in the supervised group compared to
the advice group. By the 9-month stage the advice
group score had improved from 37/100 at baseline to
31/100, a 16% improvement, however, the supervised
Fig. 2. Suitability of patients attending vascular out-patients
over a 6-month period with symptoms of intermittent
claudication to participate in a walking based exercise
programme.
 
 
Fig. 3. Change in ShortForm-36 median physical function
score over time.
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group had significantly better improvement falling
from 35/100 at baseline to 20/100, a 43% improvement
in base line score ðp , 0:05Þ.
In both groups no significant correlation was found
between smoking status and improvement in CCCQ.
Similarly number of cigarette pack years, previous
history of exercise and baseline exercise levels were
not significant predictors of improvements in CCCQ.
Absolute claudication distance
Five percent of patients were unable to perform the
treadmill test ðn ¼ 3Þ leaving 56 to be assessed at
baseline, the median score being 132 m in the
supervised group and 103 m in the advice group.
This difference was not significant. At the 3-month
stage the median treadmill distance walked was 220 m
for the supervised group, (a 67% improvement) and
119 m in the advice group (a 19% improvement), ðp ¼
0:001Þ (Fig. 5). At 6-month follow-up the median
distance walked by both groups had improved further,
being 302 m for the supervised group (129% improve-
ment) and 174 m for the advice group (69% improve-
ment) ðp ¼ 0:001Þ. Four patients, all in the supervised
group, reached the time limit of 15 min treadmill
walking representing 15% of that group. These
differences were maintained at 9 and 12-month
follow-up with the supervised group walking medians
of 305 m (131% improvement) and 304 m (130%
improvement) and the advice group walking medians
of 164 m (59% improvement) and 175 m (70%
improvement), respectively ðp ¼ 0:001Þ.
Ankle Brachial Pressure Index (ABPI)
At the 6-month follow-up the mean ABPI for the
advice group fell from 0.68 at baseline to 0.67 at 6
months. The class mean ABPI increased from 0.69–
0.71 in the same period. This difference in mean ABPI
between the two groups at 6 months was marginal and
not statistically significant ðp ¼ 0:21Þ.
Compliance with exercise
The advice given was to walk for at least half an hour
to near maximal pain at least three times a week. At 6
month review patients were asked if they had walked
,3 times, 3 times or .3 times a week (Fig. 6). Self-
reported compliance to this walking advice showed a
highly significant correlation (Pearson’s correlation)
between drop in CCCQ score, indicating improving
symptoms and claiming to walk.3 times a week ðp ¼
0:002Þ (Fig. 7). This group claimed to walk an average
of approximately five times a week. There was no
significant correlation between claiming to walk three
times a week or claiming to walk less than three times
a week and improvement in CCCQ. More than twice
as many people in the exercise class group claimed to
be walking.3 times a week compared to in the advice
group (Fig. 6).
Discussion
This prospective randomised control study gives
strong support to the hypothesis that, for sufferers of
claudication, a supervised exercise and motivation
programme, even of a relatively low intensity, gives a
significantly better improvement in walking distance
and quality of life than an advice only programme.
In 1995 a meta-analysis of 21 trials involving
various regimes of exercise for the treatment of
claudication was performed by Gardner and
Fig. 4. Mean percent score for Charing Cross Claudication
Questionnaire for class and advice groups at baseline, 3, 6
and 12-month review (higher score equates to more severe
symptoms).
 
 
 
 
  
Fig. 5. Mean absolute claudication distance for treadmill
walking (constant load, 3.5 km/h at 12% slope) for class and
advice groups at baseline, 3, 6 and 12-month review.
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Poehlman.11 This found that an average exercise
programmes produced an improvement in ACD of
122%, similar to the 129% improvement seen in the
supervised group from the 6-month point. However,
this meta-analysis was not able to show that super-
vision was a significant factor in improvement. This is
possibly due to the lack fact that only three of the 21
studies analysed were randomised controlled trials
(RCT’s) with an average of 15 patients per trial (a
quarter of the number of patients in this study).
In 2000 a Cochrane review of exercise regimes and
other therapies for the treatment of claudication
analysed 10 RCT’s with an average of 25 patients per
trial.6 This review found an average improvement in
ACD of 150%, again similar to the 126% seen in the
supervised group in this trial. The review suggested,
but could not prove, that some level of supervision
was probably beneficial but it questioned the level of
intensity required to make a significant improvement
in ACD.
This RCT chose a relatively low level of intensity of
supervision, once a week, as it was felt that this was
more achievable both logistically and financially for
most health groups. We feel that the answer to the
question of the value of supervision in exercise
therapy has been answered, and we have shown
significant results with a low intensity programme.
The value of higher intensity programmes has not
been assessed but any extra benefit would have to be
offset against the increase in cost of implementation.
The Cochrane review felt that compliance with
exercise advice, and changes in compliance should be
assessed. Monitoring devices such as Pedometers can
be used, but although accurate it can be difficult to
prove that they have not been given to the boy who
walks the dog. As some degree of honesty is required
with virtually all monitoring methods, this trial used
self-reporting.
The advice, based on the Cochrane review, had been
to walk at least three times a week. Clearly some
patients when asked at follow-up how they had
complied could be tempted to state the three times a
week per the advice. However, there appears to be a
linear relationship between weekly frequency of walks
and improvement in CCCQ score (Fig. 7). This
becomes highly significant when patients claiming to
exercise .3 times a week are compared to those
walking ,3 times a week (Fig. 7). A far greater
number of the exercise class group claimed to be
walking .3 times a week (Fig. 6). It could be
concluded that the exercise and motivation class was
successful in that it motivated class participants to
walk more frequently.
The Charing Cross Claudication Questionnaire
(CCCQ) provides a quantitative measure of improve-
ment in symptoms. Improvement in score was seen in
both the supervised and advice groups. However by
the 9-month stage the improvement from baseline of
43% in the supervised group was significantly better
than the baseline improvement of 16% in the advice
group. The CCCQ is an easy to use patient adminis-
tered questionnaire taking less than 5 min to complete.
All patients were able to complete it; it is safe and,
unlike the treadmill, requires no equipment in the
outpatient department. Ultimately this symptom
specific questionnaire tells the clinician how well the
patients are managing with their problem, and how
much it is affecting their lifestyle. This is probably
more relevant to the claudicant than the treadmill
distance they can walk. It would, therefore, seem to be
ideally suited to the outpatient setting of assessing and
monitoring of patients.
Although there was large improvement in walking
distance in the class group the results for the class
Fig. 6. Self-reported average weekly frequency of 30 min
walks to near maximum pain undertaken in the supervised
exercise and advice to exercise groups at 6-month review.
 
Fig. 7. Mean change in CCCQ score (Symptom specific
HRQL) over initial 6-month period compared to claimed
weekly frequency of walks.
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Ankle Brachial Pressure Index (ABPI) found only a
marginal, non-significant, improvement. A ‘non-sig-
nificant’ improvement in ABPI has been noted in other
studies.11 This trial was not powered on ABPI
improvement and far greater numbers would be
required to determine whether the small improvement
was indeed significant. Although ABPI is known to be
useful for the diagnosis of peripheral arterial disease,
this trial supports the view it is not as useful an
outcome measure in monitoring improvement in
claudicants’ walking ability.
This trial does not address the question of the
optimal length of a supervised programme. No
significant improvement in measured parameters
was seen after the class stopped at 6-months. A
previous trial by Creasy found significant improve-
ment at 9 and 12-month stages in patients who had
been on a 6-month supervised exercise programme
whom then continued with a regular but lower
frequency of supervision.12 Many patients expressed
the desire to continue with the classes. Would a longer
supervised programme have given further improve-
ments in the CCCQ and the ACD?
Possibly of even greater relevance to the claudicant
is that regular exercise, such as walking, has been
shown to significantly reduce cardiovascular events.13
This is of particular significance in claudicants as they
are known to suffer from a high cardiovascular
morbidity and mortality, over 75% dying from a
cardiovascular cause.2 Furthermore patients with
PAD who exercised over a 6-month period have been
shown to have a favourable improvement in cardio-
vascular risk profile, with reductions in both systolic
blood pressure and total cholesterol.14 The class
encouraged people to exercise. It may also be an
ideal opportunity to offer on-going health education
regarding reduction of cardiovascular disease risk
factors and support with lifestyle changes such as
cessation of smoking and improvement in diet.
We feel that this programme of a weekly, super-
vised, exercise motivation class has the potential to be
a cost effective, logistically viable method of signifi-
cantly improving the quality of life, and health, of
patients with mild to moderate intermittent
claudication.
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